There is increasing importance placed upon noninvasive assessment of gut inflammation.
These tools are likely to be the key in differentiating intestinal inflammatory disease from …

Introduction Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and
Ulcerative Colitis (UC), is a relapsing and remitting condition. Noninvasive biomarkers have …

Introduction: Diagnosis of the chronic inflammatory bowel diseases relies upon initial
recognition of an inflammatory condition, followed by definitive endoscopic, histological and …

Diagnosis and prognosis of inflammatory bowel disease (IBD)—a chronic inflammation that
affects the gastrointestinal tract of patients—are challenging, as most clinical symptoms are …

It is often difficult to assess disease activity in inflammatory bowel disease (IBD).
Noninvasive biomarkers are a means of quantifying often nebulous symptoms without …

Background: Inflammatory bowel disease (IBD) is a chronically relapsing disease with a
continuous need for proactive monitoring to decide appropriate treatments and follow-up …

Objective. There is increasing knowledge of the pathophysiology behind inflammatory bowel
disease (IBD) although the exact mechanism is far from fully understood. In the era of new …

Recent observations suggest that subjective measures of disease activity in inflammatory
bowel disease (IBD) are often misleading. Objective measures of inflammation are more …

Despite advances in our understanding of the pathophysiology underlying inflammatory
bowel disease, there remains a significant need for biomarkers that can differentiate …

There is currently no gold standard test for the diagnosis of inflammatory bowel disease
(IBD). Physicians must rely on a number of diagnostic tools including clinical and …